CBNK Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
84.3M
+3.7%
81.3M
+0.3%
81.1M
+6.8%
76.0M
-2.2%
77.7M
Cost of Revenue
19.0M
+2.5%
18.6M
+1.2%
18.4M
+42.6%
12.9M
-24.0%
16.9M
Gross Profit
65.3M
+4.0%
62.8M
+0.0%
62.7M
-0.5%
63.1M
+3.8%
60.8M
Operating Expenses
43.2M
-1.1%
43.7M
+11.7%
39.1M
+2.0%
38.4M
-3.1%
39.6M
R&D
SG&A
17.4M
-1.8%
17.8M
+12.2%
15.8M
+10.3%
14.3M
+0.3%
14.3M
Operating Income
18.5M
+16.3%
15.9M
-19.4%
19.7M
-0.9%
19.9M
+16.2%
17.1M
EBITDA
18.5M
+16.3%
15.9M
-19.4%
19.7M
-4.3%
20.6M
+11.2%
18.5M
Net Income
14.3M
+18.6%
12.0M
-20.1%
15.0M
-0.2%
15.1M
+14.7%
13.1M
EPS (Basic)
$0.87
+17.6%
$0.74
-18.7%
$0.91
+0.0%
$0.91
+15.2%
$0.79
EPS (Diluted)
$0.87
+19.2%
$0.73
-19.8%
$0.91
+2.2%
$0.89
+14.1%
$0.78
Shares (Diluted)
16.4M
-0.4%
16.4M
-0.4%
16.5M
-2.0%
16.8M
+0.3%
16.8M
Capital Ban (CBNK) — Financials